SCHEMBL6537334

SCHEMBL6537334

O=C(Nc1cccc2cc(Br)cnc12)c1cccc(Cl)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.70
MEN1 O00255 1/20 0.70
KMT2A Q03164 1/20 0.70
KDR P35968 5/20 0.56
KCNQ3 O43525 2/20 0.52
KCNQ2 O43526 2/20 0.52
KCNE1 P15382 2/20 0.52
KCNQ1 P51787 2/20 0.52
KCNQ5 Q9NR82 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
GAA P10253 1/20 0.52
KCNMA1 Q12791 1/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
TP53 P04637 1/20 0.49
MAPT P10636 1/20 0.49
HTT P42858 1/20 0.49
GRM5 P41594 1/20 0.49
GPR35 Q9HC97 1/20 0.48
ALDH1A1 P00352 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538190 0.89 KDR (0.67) L3MBTL1MEN1KMT2AKDRTDP1
SCHEMBL6537872 0.86 KDR (0.57) L3MBTL1MEN1KMT2AKDRTDP1
SCHEMBL6538118 0.85 KDR (0.56) L3MBTL1MEN1KMT2AKDRTDP1
SCHEMBL6537795 0.85 NPC1 (0.70) L3MBTL1MEN1KMT2AKDRTDP1
SCHEMBL6537930 0.83 KDR (0.54) L3MBTL1MEN1KMT2AKDRTDP1
SCHEMBL6537536 0.82 KDR (0.52) L3MBTL1MEN1KMT2AKDRTDP1
SCHEMBL6537726 0.82 TDP1 (0.61) L3MBTL1MEN1KMT2AKDRTDP1
SCHEMBL6538099 0.82 CLK1 (0.55) L3MBTL1MEN1KMT2AKDRTDP1
SCHEMBL6537710 0.82 KDR (0.53) L3MBTL1MEN1KMT2AKDRTDP1
SCHEMBL6537714 0.82 KMT2A (0.61) MEN1KMT2AKDRKCNQ3KCNQ2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed